Meet the investigator: Daniel D. Billadeau, Ph.D.
At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.
Related
This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.
Related Posts
![](https://cdn.prod-carehubs.net/n1/64bf9b8fff067424/uploads/2024/05/Plane16x9.jpg)
After a pancreatic cancer diagnosis and multiple cardiac arrests during treatment, "Tiger" Dick Whetstone finds help and hope at Mayo Clinic.
![](https://cdn.prod-carehubs.net/n1/64bf9b8fff067424/uploads/2022/10/shutterstock_1220075.jpg)
Dr. Maria Linnaus discusses the link between obesity and cancer risk and how bariatric surgery may reduce that risk.
![](https://cdn.prod-carehubs.net/n1/64bf9b8fff067424/uploads/2023/12/GettyImages-1692135515.jpg)
They identified a cell-signaling protein that drives pancreatic cancer cell growth that could be a potential therapeutic target.